Meniscal and Articular Cartilage Predictors of Outcome After Revision ACL Reconstruction: A 6-Year Follow-up Cohort Study.


Journal

The American journal of sports medicine
ISSN: 1552-3365
Titre abrégé: Am J Sports Med
Pays: United States
ID NLM: 7609541

Informations de publication

Date de publication:
03 2023
Historique:
pmc-release: 01 03 2024
pubmed: 4 2 2023
medline: 3 3 2023
entrez: 3 2 2023
Statut: ppublish

Résumé

Meniscal and chondral damage is common in the patient undergoing revision anterior cruciate ligament (ACL) reconstruction. To determine if meniscal and/or articular cartilage pathology at the time of revision ACL surgery significantly influences a patient's outcome at 6-year follow-up. Cohort study; Level of evidence, 3. Patients undergoing revision ACL reconstruction were prospectively enrolled between 2006 and 2011. Data collection included baseline demographics, surgical technique, pathology, treatment, and scores from 4 validated patient-reported outcome instruments: International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome Score (KOOS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Marx Activity Rating Scale. Patients were followed up at 6 years and asked to complete the identical set of outcome instruments. Regression analysis assessed the meniscal and articular cartilage pathology risk factors for clinical outcomes 6 years after revision ACL reconstruction. An overall 1234 patients were enrolled (716 males, 58%; median age, 26 years). Surgeons reported the pathology at the time of revision surgery in the medial meniscus (45%), lateral meniscus (36%), medial femoral condyle (43%), lateral femoral condyle (29%), medial tibial plateau (11%), lateral tibial plateau (17%), patella (30%), and trochlea (21%). Six-year follow-up was obtained on 79% of the sample (980/1234). Meniscal pathology and articular cartilage pathology (medial femoral condyle, lateral femoral condyle, lateral tibial plateau, trochlea, and patella) were significant drivers of poorer patient-reported outcomes at 6 years (IKDC, KOOS, WOMAC, and Marx). The most consistent factors driving outcomes were having a medial meniscal excision (either before or at the time of revision surgery) and patellofemoral articular cartilage pathology. Six-year Marx activity levels were negatively affected by having either a repair/excision of the medial meniscus (odds ratio range, 1.45-1.72; Meniscal and chondral pathology at the time of revision ACL reconstruction has continued significant detrimental effects on patient-reported outcomes at 6 years after revision surgery.

Sections du résumé

BACKGROUND
Meniscal and chondral damage is common in the patient undergoing revision anterior cruciate ligament (ACL) reconstruction.
PURPOSE
To determine if meniscal and/or articular cartilage pathology at the time of revision ACL surgery significantly influences a patient's outcome at 6-year follow-up.
STUDY DESIGN
Cohort study; Level of evidence, 3.
METHODS
Patients undergoing revision ACL reconstruction were prospectively enrolled between 2006 and 2011. Data collection included baseline demographics, surgical technique, pathology, treatment, and scores from 4 validated patient-reported outcome instruments: International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome Score (KOOS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Marx Activity Rating Scale. Patients were followed up at 6 years and asked to complete the identical set of outcome instruments. Regression analysis assessed the meniscal and articular cartilage pathology risk factors for clinical outcomes 6 years after revision ACL reconstruction.
RESULTS
An overall 1234 patients were enrolled (716 males, 58%; median age, 26 years). Surgeons reported the pathology at the time of revision surgery in the medial meniscus (45%), lateral meniscus (36%), medial femoral condyle (43%), lateral femoral condyle (29%), medial tibial plateau (11%), lateral tibial plateau (17%), patella (30%), and trochlea (21%). Six-year follow-up was obtained on 79% of the sample (980/1234). Meniscal pathology and articular cartilage pathology (medial femoral condyle, lateral femoral condyle, lateral tibial plateau, trochlea, and patella) were significant drivers of poorer patient-reported outcomes at 6 years (IKDC, KOOS, WOMAC, and Marx). The most consistent factors driving outcomes were having a medial meniscal excision (either before or at the time of revision surgery) and patellofemoral articular cartilage pathology. Six-year Marx activity levels were negatively affected by having either a repair/excision of the medial meniscus (odds ratio range, 1.45-1.72;
CONCLUSION
Meniscal and chondral pathology at the time of revision ACL reconstruction has continued significant detrimental effects on patient-reported outcomes at 6 years after revision surgery.

Identifiants

pubmed: 36734487
doi: 10.1177/03635465231151389
pmc: PMC10338044
mid: NIHMS1904042
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-614

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR060846
Pays : United States

Références

Am J Sports Med. 2020 Oct;48(12):2978-2985
pubmed: 32822238
Arthroscopy. 1997 Aug;13(4):456-60
pubmed: 9276052
J Orthop Surg Res. 2020 Jan 10;15(1):9
pubmed: 31924236
Am J Sports Med. 2016 Mar;44(3):580-4
pubmed: 26672024
Knee Surg Sports Traumatol Arthrosc. 2019 Jan;27(1):137-145
pubmed: 30014185
Am J Sports Med. 2012 Jul;40(7):1551-7
pubmed: 22562791
Knee Surg Sports Traumatol Arthrosc. 2018 Apr;26(4):1059-1064
pubmed: 29516122
J Bone Joint Surg Am. 2012 Mar 21;94(6):531-6
pubmed: 22438002
Int Orthop. 2013 Jul;37(7):1369-74
pubmed: 23624910
Arch Orthop Trauma Surg. 2012 Jun;132(6):867-74
pubmed: 22350055
Knee Surg Sports Traumatol Arthrosc. 2006 Nov;14(11):1130-8
pubmed: 16951974
Am J Sports Med. 2016 Jul;44(7):1671-9
pubmed: 27161867
J Knee Surg. 2019 Mar;32(3):218-221
pubmed: 29653445
Eur J Orthop Surg Traumatol. 2019 Jan;29(1):157-161
pubmed: 30022240
Orthop J Sports Med. 2020 Oct 28;8(10):2325967120960538
pubmed: 33195722
Am J Sports Med. 2020 Aug;48(10):2418-2428
pubmed: 32736502
Am J Sports Med. 2006 Oct;34(10):1604-14
pubmed: 16685086
Knee Surg Sports Traumatol Arthrosc. 2011 Feb;19(2):196-201
pubmed: 20644911
Knee Surg Sports Traumatol Arthrosc. 2015 Oct;23(10):2825-45
pubmed: 26202138
Am J Sports Med. 2018 Apr;46(5):1137-1142
pubmed: 29382207
Am J Sports Med. 2008 Oct;36(10):1889-95
pubmed: 18490470

Auteurs

Rick W Wright (RW)

Vanderbilt University, Nashville, Tennessee, USA.

Laura J Huston (LJ)

Vanderbilt University, Nashville, Tennessee, USA.

Amanda K Haas (AK)

Washington University in St Louis, St Louis, Missouri, USA.

Jacquelyn S Pennings (JS)

Vanderbilt University, Nashville, Tennessee, USA.

Christina R Allen (CR)

Yale University, New Haven, Connecticut, USA.

Daniel E Cooper (DE)

WB Carrell Memorial Clinic, Dallas, Texas, USA.

Thomas M DeBerardino (TM)

The San Antonio Orthopaedic Group, San Antonio, Texas, USA.

Warren R Dunn (WR)

Texas Orthopedic Hospital, Houston, Texas, USA.

Brett Brick A Lantz (BBA)

Slocum Research and Education Foundation, Eugene, Oregon, USA.

Kurt P Spindler (KP)

Cleveland Clinic, Cleveland, Ohio, USA.

Michael J Stuart (MJ)

Mayo Clinic, Rochester, Minnesota, USA.

John P Albright (JP)

University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

Annunziato Ned Amendola (AN)

Duke University, Durham, North Carolina, USA.

Jack T Andrish (JT)

Cleveland Clinic, Cleveland, Ohio, USA.

Christopher C Annunziata (CC)

Commonwealth Orthopaedics and Rehabilitation, Arlington, Virginia, USA.

Robert A Arciero (RA)

University of Connecticut Health Center, Farmington, Connecticut, USA.

Bernard R Bach (BR)

Rush University Medical Center, Chicago, Illinois, USA.

Champ L Baker (CL)

The Hughston Clinic, Columbus, Georgia, USA.

Arthur R Bartolozzi (AR)

3B Orthopaedics, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.

Keith M Baumgarten (KM)

Orthopedic Institute, Sioux Falls, South Dakota, USA.

Jeffery R Bechler (JR)

University Orthopaedic Associates LLC, Princeton, New Jersey, USA.

Jeffrey H Berg (JH)

Town Center Orthopaedic Associates, Reston, Virginia, USA.

Geoffrey A Bernas (GA)

State University of New York at Buffalo, Buffalo, NY.

Stephen F Brockmeier (SF)

University of Virginia, Charlottesville, Virginia, USA.

Robert H Brophy (RH)

Washington University in St Louis, St Louis, Missouri, USA.

Charles A Bush-Joseph (CA)

Rush University Medical Center, Chicago, Illinois, USA.

J Brad Butler (JB)

Orthopedic and Fracture Clinic, Portland, Oregon, USA.

John D Campbell (JD)

Bridger Orthopedic and Sports Medicine, Bozeman, Montana, USA.

James L Carey (JL)

University of Pennsylvania, Philadelphia, Pennsylvania, USA.

James E Carpenter (JE)

University of Michigan, Ann Arbor, Michigan, USA.

Brian J Cole (BJ)

Rush University Medical Center, Chicago, Illinois, USA.

Jonathan M Cooper (JM)

HealthPartners Specialty Center, St Paul, Minnesota, USA.

Charles L Cox (CL)

Vanderbilt University, Nashville, Tennessee, USA.

R Alexander Creighton (RA)

University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.

Diane L Dahm (DL)

Mayo Clinic, Rochester, Minnesota, USA.

Tal S David (TS)

Synergy Specialists Medical Group, San Diego, California, USA.

David C Flanigan (DC)

The Ohio State University, Columbus, Ohio, USA.

Robert W Frederick (RW)

The Rothman Institute/Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Theodore J Ganley (TJ)

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Elizabeth A Garofoli (EA)

Washington University in St Louis, St Louis, Missouri, USA.

Charles J Gatt (CJ)

University Orthopaedic Associates LLC, Princeton, New Jersey, USA.

Steven R Gecha (SR)

Princeton Orthopaedic Associates, Princeton, New Jersey, USA.

James Robert Giffin (JR)

Fowler Kennedy Sport Medicine Clinic, University of Western Ontario, London, Ontario, Canada.

Sharon L Hame (SL)

David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Jo A Hannafin (JA)

Hospital for Special Surgery, New York, New York, USA.

Christopher D Harner (CD)

University of Texas Health Center, Houston, Texas, USA.

Norman Lindsay Harris (NL)

Grand River Health, Rifle, Colorado, USA.

Keith S Hechtman (KS)

UHZ Sports Medicine Institute, Coral Gables, Florida, USA.

Elliott B Hershman (EB)

Lenox Hill Hospital, New York, New York, USA.

Rudolf G Hoellrich (RG)

Slocum Research and Education Foundation, Eugene, Oregon, USA.

David C Johnson (DC)

National Sports Medicine Institute, Leesburg, Virginia, USA.

Timothy S Johnson (TS)

National Sports Medicine Institute, Leesburg, Virginia, USA.

Morgan H Jones (MH)

Cleveland Clinic, Cleveland, Ohio, USA.

Christopher C Kaeding (CC)

The Ohio State University, Columbus, Ohio, USA.

Ganesh V Kamath (GV)

University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.

Thomas E Klootwyk (TE)

Methodist Sports Medicine, Indianapolis, Indiana, USA.

Bruce A Levy (BA)

Mayo Clinic Rochester, Minnesota, USA.

C Benjamin Ma (CB)

University of California, San Francisco, California, USA.

G Peter Maiers (GP)

Methodist Sports Medicine Center, Indianapolis, Indiana, USA.

Robert G Marx (RG)

Hospital for Special Surgery, New York, New York, USA.

Matthew J Matava (MJ)

Washington University in St Louis, St Louis, Missouri, USA.

Gregory M Mathien (GM)

Knoxville Orthopaedic Clinic, Knoxville, Tennessee, USA.

David R McAllister (DR)

David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Eric C McCarty (EC)

University of Colorado Denver School of Medicine, Denver, Colorado, USA.

Robert G McCormack (RG)

University of British Columbia/Fraser Health Authority, British Columbia, Canada.

Bruce S Miller (BS)

University of Michigan, Ann Arbor, Michigan, USA.

Carl W Nissen (CW)

Connecticut Children's Medical Center, Hartford, Connecticut, USA.

Daniel F O'Neill (DF)

Littleton Regional Healthcare, Littleton, New Hampshire, USA.

Brett D Owens (BD)

Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.

Richard D Parker (RD)

Cleveland Clinic, Cleveland, Ohio, USA.

Mark L Purnell (ML)

Aspen Orthopedic Associates, Aspen, Colorado, USA.

Arun J Ramappa (AJ)

Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Michael A Rauh (MA)

State University of New York at Buffalo, Buffalo, New York, USA.

Arthur C Rettig (AC)

Methodist Sports Medicine, Indianapolis, Indiana, USA.

Jon K Sekiya (JK)

University of Michigan, Ann Arbor, Michigan, USA.

Kevin G Shea (KG)

Intermountain Orthopaedics, Boise, Idaho, USA.

Orrin H Sherman (OH)

NYU Hospital for Joint Diseases, New York, New York, USA.

James R Slauterbeck (JR)

University of South Alabama, Mobile, Alabama, USA.

Matthew V Smith (MV)

Washington University in St Louis, St Louis, Missouri, USA.

Jeffrey T Spang (JT)

University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.

Ltc Steven J Svoboda (LSJ)

Keller Army Community Hospital, United States Military Academy, West Point, New York, USA.

Timothy N Taft (TN)

University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.

Joachim J Tenuta (JJ)

Albany Medical Center, Albany, New York, USA.

Edwin M Tingstad (EM)

Inland Orthopaedic Surgery and Sports Medicine Clinic, Pullman, Washington, USA.

Armando F Vidal (AF)

University of Colorado Denver School of Medicine, Denver, Colorado, USA.

Darius G Viskontas (DG)

Royal Columbian Hospital, New Westminster, British Columbia, Canada.

Richard A White (RA)

Fitzgibbon's Hospital, Marshall, Missouri, USA.

James S Williams (JS)

Cleveland Clinic, Euclid, Ohio, USA.

Michelle L Wolcott (ML)

University of Colorado Denver School of Medicine, Denver, Colorado, USA.

Brian R Wolf (BR)

University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

James J York (JJ)

Orthopaedic and Sports Medicine Center, LLC, Pasedena, Maryland, USA.
Investigation performed at Vanderbilt University, Nashville, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH